Richard B. Tunnicliffe
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Fragment-Based Development of Small Molecule Inhibitors Targeting Mycobacterium tuberculosis Cholesterol Metabolism.
Journal: Journal of medicinal chemistry
Published: July 14, 2025
Fragment-based development of small molecule inhibitors targeting Mycobacterium tuberculosis cholesterol metabolism.
Journal: bioRxiv : the preprint server for biology
Published: January 13, 2025
Expression and purification of Mycobacterium tuberculosis F420-dependent glucose-6-phosphate dehydrogenase enzyme using Escherichia coli.
Journal: Protein expression and purification
Published: October 28, 2024
Structure Based Discovery of Inhibitors of CYP125 and CYP142 from Mycobacterium tuberculosis.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: December 10, 2022
A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen).
Journal: European journal of medicinal chemistry
Published: October 25, 2021
Molecular Mechanism of SR Protein Kinase 1 Inhibition by the Herpes Virus Protein ICP27.
Journal: mBio
Published: October 24, 2019
Studies of the oligomerisation mechanism of a cystatin-based engineered protein scaffold.
Journal: Scientific reports
Published: April 01, 2019
Structural identification of conserved RNA binding sites in herpesvirus ORF57 homologs: implications for PAN RNA recognition.
Journal: Nucleic acids research
Published: September 28, 2018
Overlapping motifs on the herpes viral proteins ICP27 and ORF57 mediate interactions with the mRNA export adaptors ALYREF and UIF.
Journal: Scientific reports
Published: July 30, 2018
The herpes viral transcription factor ICP4 forms a novel DNA recognition complex.
Journal: Nucleic acids research
Published: January 27, 2017
Last Updated: 09/26/2026